Equator Therapeutics
YC W20 · Active · We are developing a drug to burn calories and increase metabolism…
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 AlixiaShared: therapeutics, biotech, drugActiveOther | Other | Active | YCW22 |
 SynsoryBioShared: therapeutics, biotech, drugActiveOther | Other | Active | YCW24 |
 Eris BiotechShared: therapeutics, biotech, drugActiveOther | Other | Active | YCW24 |
 Origami Therapeutics, Inc.Shared: therapeutics, biotech, drugActiveOther | Other | Active | YCW22 |
 Exin TherapeuticsShared: therapeutics, biotech, drugActiveAI | AI | Active | YCW25 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 Gerostate AlphaShared: therapeutics, biotech, developingInactiveOther | Other | Inactive | YCS18 |
 Velorum TherapeuticsShared: therapeutics, biotech, developingActiveOther | Other | Active | YCW24 |
 Valink TherapeuticsShared: therapeutics, biotech, drugActiveOther | Other | Active | YCW21 |
 Intact TherapeuticsShared: therapeutics, drug, developingActiveOther | Other | Active | YCW19 |
 Evolvere BioSciencesShared: therapeutics, biotech, drugActiveAI | AI | Active | YCS24 |
Also from W20
All of W20
About Equator Therapeutics
We are developing a drug to increase metabolism and burn calories without exercise. Obesity and type 2 diabetes have reached epidemic proportions. There are 2.2B overweight people and 500M people with type 2 diabetes worldwide, and these numbers increase drastically every year. Existing drugs are not effective enough to reverse the trend. Our drug can solve this problem, because it addresses the root cause of metabolic disorders – the imbalance between caloric intake and expenditure. Our drug will target mitochondria – the powerhouse of the cell – to generate heat. This approach has been proven to fully reverse obesity and type 2 diabetes in animals. However, therapeutic application for humans was impossible, because mitochondrial heat production could only be induced by highly artificial methods with side effects. This changed after our recent breakthrough discovery of the protein that mitochondria naturally use to generate heat. We have developed a unique high-throughput drug discovery platform to identify compounds that selectively activate this target protein, without side effects. For decades people have wanted a drug that burns calories like exercise does. We are realizing this dream at Equator Therapeutics.
- YC batch
- W20 · Winter 2020
- Status, per YC
- Active
- Category
- Other
- Team size
- 2
- Location
- San Francisco, CA, USA
- Checked
- 1h ago
YC tags: Biotech, Therapeutics
Equator Therapeutics: questions
Which YC batch was Equator Therapeutics in?
Equator Therapeutics was in Y Combinator's Winter 2020 batch (W20).
Is Equator Therapeutics still active?
Y Combinator lists Equator Therapeutics as active.
Where is Equator Therapeutics based?
Equator Therapeutics lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.